Evaluation of Adjuvant Effect of Ayurvedic Medicine in Oxygen Dependant COVID 19 Patients

Evaluation of Adjuvant Effect of Ayurvedic Herbo-mineral Medicine in Oxygen Dependant COVID 19 Pneumonia Patients - A Double Blind Placebo Controlled Study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033899

Enrollment

Registered

2021-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurvedic Herbo-mineral capsule with standard modern treatment: Sahasra Puti Abhraka Bhasma 22 mg, Hrudayarnava Rasa 42 mg, Swarna Vasanta Malati 42 mg and Trikatu Churna 396 mg orally

Eligibility

Inclusion criteria

Inclusion criteria: 1.Confirmed cases of COVID 19 pneumonia who require oxygen support. 2.Subjects willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who are known cases of immune-compromised or autoimmune condition such as HIV. 2. Pregnant and lactating women. 3. Patients needing intensive care or ventilator support.

Design outcomes

Primary

Measure	Time frame
effect of Ayurvedic herbo-mineral combination on SpO2 levels in oxygen dependent COVID 19 pneumonia patients in comparison with placebo.Timepoint: From baseline till the end of seven days	—

Secondary

Measure	Time frame
effect of Ayurvedic herbo-mineral combination on oxygen supply per minute and symptoms seen in patients in oxygen dependent COVID 19 pneumonia patients in comparison with placeboTimepoint: From baseline till the end of seven days	—

Countries

India

Contacts

Public ContactDr Harish Daga

Parul Institute of Ayurveda

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026